Since 1978, Growth hormone (GH) has been used to treat patients with GH deficiency in Hong Kong. In 1998, the Hospital Authority expanded the use of GH in children with Turner syndrome and chronic renal failure before transplantation. Two additional indications for GH treatment, Prader-Willi syndrome and short stature homeobox-containing gene disorders have been approved in 2012. The objective of this paper is to discuss the recommendations of GH treatment for children and adolescents with these conditions in Hong Kong.
展开▼